(Q34346439)

1 August 2017

Frequency of human CYP2D6 mutant alleles in a normal Chinese population (English)

1 reference

1 August 2017

Lee EJ

1

1 reference

PubMed ID

7917781

1 August 2017

Jeyaseelan K

series ordinal

2

1 reference

PubMed ID

7917781

1 August 2017

language of work or name

English

0 references

publication date

1 June 1994

1 reference

British Journal of Clinical Pharmacology

1 August 2017

1 reference

1 August 2017

37

1 reference

1 August 2017

605-607

1 reference

1 August 2017

6

1 reference

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364822

Oxidation phenotyping in Chinese and Malay populations

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364822

Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364822

Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364822

Distinct phenotypes and genotypes of debrisoquine hydroxylation among Europeans and Chinese

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364822

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364822

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364822

Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364822

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

27 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1994.TB04311.X

Debrisoquine phenotype and genotype in Chinese

21 January 2018

1 reference

12 December 2020

Low frequency of slow debrisoquine hydroxylation in a native Chinese population

1 reference

12 December 2020

Measurement of debrisoquine and 4-hydroxydebrisoquine in urine by liquid chromatography

1 reference

12 December 2020

Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6

1 reference

12 December 2020

Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype

1 reference

12 December 2020

Polymorphic debrisoquin hydroxylation in 757 Swedish subjects

1 reference

12 December 2020

Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine

1 reference

12 December 2020

10.1111/J.1365-2125.1994.TB04311.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

PubMed ID

7917781